New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
12:31 EDTENMD
theflyonthewall.com: EntreMed's ENMD-2076 active in solid and hematological cancers
EntreMed announced the presentation of data for the Phase 1 study for its Aurora A/angiogenic kinase inhibitor, ENMD-2076, in leukemia patients. The Company also announced that it has selected ovarian cancer as an initial Phase 2 indication. :theflyonthewall.com



News For ENMD From The Last 14 Days
Check below for free stories on ENMD the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2010
16:16 EDTENMD
theflyonthewall.com: EntreMed sells 3.85M shares at 65c in a registered direct offering

Subscribe for More Information :theflyonthewall.com